Valuation: Guided Therapeutics, Inc.

Market Cap 25.58M 22.46M 20.94M 19.25M 36.08M 2.45B 36.69M 247M 97.05M 1.21B 96.03M 93.96M 4.19B P/E 2024
-3x
P/E 2025 -12.7x
Enterprise Value 28.46M 24.99M 23.3M 21.42M 40.14M 2.73B 40.82M 275M 108M 1.35B 107M 105M 4.66B EV / Sales 2024
1,649x
EV / Sales 2025 64.4x
Free-Float
63.48%
Yield 2024 *
-
Yield 2025 -
1 week-16.73%
Current month-4.58%
1 month-4.58%
3 months+14.50%
6 months-41.28%
Current year-57.59%
1 week 0.2
Extreme 0.2
0.27
1 month 0.2
Extreme 0.2
0.32
Current year 0.17
Extreme 0.17
0.54
1 year 0.12
Extreme 0.1231
0.54
3 years 0.06
Extreme 0.064
0.54
5 years 0.06
Extreme 0.062
0.78
10 years 0.02
Extreme 0.0206
3,200
Manager TitleAgeSince
Chief Executive Officer 70 06/03/2023
Chief Tech/Sci/R&D Officer 70 02/12/2010
Director TitleAgeSince
Director/Board Member 70 01/12/2016
Director/Board Member 76 10/04/2006
Chairman 67 01/10/2013
Date Insider Type Main position Quantity % Market Cap.
3/10/26 A Others

Director

10 0.9747%
3/10/26 A Free

Chairman

110,000 0.1316%
3/10/26 A Free

Director

110,000 0.1316%
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-16.73%-8.40%+52.67% 25.58M
+3.02%+9.54%+20.51%+2.93% 208B
+1.30%-1.02%-3.13%-22.02% 138B
+1.39%+2.44%-27.04%+11.82% 126B
+1.21%+5.23%-56.60%-12.50% 67.64B
+0.77%-1.55%+4.60%+1.22% 47.81B
+1.01%+1.61%-25.12%-32.86% 45.03B
+1.92%+7.89%+16.94%+10.96% 38.94B
+3.42%+7.37%+26.72%+34.60% 36.45B
+2.90%+5.21%-24.06%-5.66% 29.29B
Average +1.69%+0.93%-7.56%+4.11% 73.73B
Weighted average by Cap. +1.94%+1.40%-4.59%-2.29%

Financials

2024 2025
Net sales 7K 6.15K 5.73K 5.27K 9.87K 671K 10.04K 67.71K 26.56K 331K 26.28K 25.71K 1.15M 767K 673K 628K 577K 1.08M 73.51M 1.1M 7.42M 2.91M 36.31M 2.88M 2.82M 126M
Net income -2.42M -2.12M -1.98M -1.82M -3.41M -232M -3.47M -23.38M -9.17M -114M -9.07M -8.88M -396M -3.2M -2.81M -2.62M -2.41M -4.51M -306M -4.58M -30.91M -12.12M -151M -12M -11.74M -523M
Net Debt 1.77M 1.55M 1.45M 1.33M 2.5M 170M 2.54M 17.13M 6.72M 83.84M 6.65M 6.5M 290M 2.88M 2.53M 2.35M 2.16M 4.06M 276M 4.12M 27.82M 10.91M 136M 10.8M 10.56M 471M
Logo Guided Therapeutics, Inc.
Guided Therapeutics, Inc. is a medical technology company. The Company is focused on developing medical devices that have the potential to improve healthcare. The Company’s primary focus is the sales and marketing of its LuViva Advanced Cervical Scan non-invasive cervical cancer detection device. The underlying technology of LuViva primarily relates to the use of biophotonics for the non-invasive detection of cancers. LuViva is designed to identify cervical cancers and precancers painlessly, non-invasively and at the point of care by scanning the cervix with light, then analyzing the reflected and fluorescent light. LuViva is designed to provide a less invasive and painless alternative to conventional tests for cervical cancer screening and detection. Additionally, LuViva is designed to improve patient well-being not only because it eliminates pain, but also because it is convenient to use and provides rapid results at the point of care.
Employees
3
Date Price Change Volume
28/07/26 $0.2440 -7.92% 3,050
27/07/26 $0.2650 +1.92% 6,091
23/07/26 $0.2600 -3.70% 5,100
22/07/26 $0.2700 -0.47% 310
21/07/26 $0.2713 -1.35% 5,500
  1. Stock Market
  2. Stocks
  3. GTHP Stock